FDA Gets Mylan Suit Over Generic Lipitor Tossed
A federal judge in Washington on Monday tossed Mylan Pharmaceuticals Inc.'s suit to compel the U.S. Food and Drug Administration to weigh in on Ranbaxy Laboratories Ltd.'s exclusivity provision for marketing...To view the full article, register now.
Already a subscriber? Click here to view full article